A wearable device that automatically regulates blood-sugar levels was found to help Type 1 diabetics better manager their condition, according to a new study which was reported in the Wall Street Journal September 29 (Page A3). The wearable “iLet bionic pancreas†made by Beta Bionics helped people reduce their average blood-sugar levels more effectively than other treatment methods, according to a study which was published in the New England Journal of Medicine. Although the Food & Drug Administration (FDA) has yet to approve the iLet for distribution in the U.S., the agency in 2019 granted it breakthrough-device designation to speed up the review process. The FDA has already cleared other automated insulin-delivery systems so the outlook for receiving approval looks good.
